Advertisement

Topics

Krystal seeks FDA nod for rare skin blistering disorder drug

06:08 EDT 28 Mar 2018 | SmartBrief

An investigative new drug application was filed by Krystal Biotech to the FDA for a Phase I/II clinical study of KB103 in pat -More

Original Article: Krystal seeks FDA nod for rare skin blistering disorder drug

NEXT ARTICLE

More From BioPortfolio on "Krystal seeks FDA nod for rare skin blistering disorder drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...